Sleep medicine Centers of Western New York Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2008
NCT01401413
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Alternative names

Sleep Medicine Centers of WNY

Active Ingredients

Drugs in Phase 4 Trials (1)

ramelteon (rozerem) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Mental Disorders (Phase 4)

REM Sleep Behavior Disorder (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1